Department of Chemistry (H.-Y.Y., C.V.R.) Kavli Institute for Nanoscience Discovery (C.V.R.), University of Oxford, Oxford, UK; OMass Pharmaceuticals Ltd., Oxford, UK (H.-Y.Y., A.J.); and Institute of Biological Chemistry, Academia Sinica, Taipei, Taiwan (H.-Y.Y.)

Department of Chemistry (H.-Y.Y., C.V.R.) Kavli Institute for Nanoscience Discovery (C.V.R.), University of Oxford, Oxford, UK; OMass Pharmaceuticals Ltd., Oxford, UK (H.-Y.Y., A.J.); and Institute of Biological Chemistry, Academia Sinica, Taipei, Taiwan (H.-Y.Y.)

Department of Chemistry (H.-Y.Y., C.V.R.) Kavli Institute for Nanoscience Discovery (C.V.R.), University of Oxford, Oxford, UK; OMass Pharmaceuticals Ltd., Oxford, UK (H.-Y.Y., A.J.); and Institute of Biological Chemistry, Academia Sinica, Taipei, Taiwan (H.-Y.Y.)